Oxidative stress-related aging: A role for prostate cancer?

Prostate cancer has the highest prevalence of any non-cutaneous cancer in the human body and essentially all men with circulating androgens will develop microscopic prostate cancer if they live long enough. Aging, considered as an impairment of body functions over time, caused by the accumulation of molecular damage in DNA, proteins and lipids, is also characterized by an increase in intracellular oxidative stress due to the progressive decrease of the intracellular ROS scavenging. The aging damage may eventually appear in age-related health issues, which have a significant impact on the independence, general well-being and morbidity of the elderly. The association of aging with prostate cancer is undisputable as well as the association of aging with oxidative stress. Nevertheless, supportive evidence linking an increase in oxidative stress with prostate cancer is still scarce. This review is a comprehensive, literature-based analysis of the association of human prostate cancer with oxidative stress. The objective was to examine the involvement of reactive oxygen species in the mechanisms of prostatic carcinogenesis since the understanding of risk factors for prostate cancer has practical importance for public health, genetic and nutritional education, and chemoprevention.

[1]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[2]  Makoto Kobayashi,et al.  Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. , 2005, Antioxidants & redox signaling.

[3]  G. Barja.  Rate of generation of oxidative stress-related damage and animal longevity. , 2002, Free radical biology & medicine.

[4]  M. Evans,et al.  Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. , 2004, Carcinogenesis.

[5]  W. Drake,et al.  The endocrine system and ageing , 2007, The Journal of pathology.

[6]  G. Francini,et al.  Weekly high‐dose calcitriol and docetaxel in patients with metastatic hormone‐refractory prostate cancer previously exposed to docetaxel , 2007, BJU international.

[7]  J. Martin,et al.  The pathology of ageing: concepts and mechanisms , 2007, The Journal of pathology.

[8]  Georg Bartsch,et al.  Cancer of the prostate. , 2005, Critical reviews in oncology/hematology.

[9]  M. Reed,et al.  Impaired angiogenesis in the aged. , 2004, Science of Aging Knowledge Environment.

[10]  G. Untergasser,et al.  The ageing male reproductive tract , 2007, The Journal of pathology.

[11]  B. Rosner,et al.  Relation of serum vitamins A and E and carotenoids to the risk of cancer. , 1984, The New England journal of medicine.

[12]  P. Pelicci,et al.  Apoptosis and aging: role of p66Shc redox protein. , 2006, Antioxidants & redox signaling.

[13]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[14]  D. Sinclair.  Toward a unified theory of caloric restriction and longevity regulation , 2005, Mechanisms of Ageing and Development.

[15]  J. Auwerx,et al.  Sirtuin functions in health and disease. , 2007, Molecular endocrinology.

[16]  T. Finkel.  Reactive Oxygen Species and Signal Transduction , 2001, IUBMB life.

[17]  K. Naber,et al.  Chronic prostatitis-an infectious disease? , 2000, The Journal of antimicrobial chemotherapy.

[18]  M. Kohli,et al.  Thrombin receptor expression is upregulated in prostate cancer , 2006, The Prostate.

[19]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[20]  A. Kristal,et al.  Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. , 2008, Carcinogenesis.

[21]  A. Bokov,et al.  The role of oxidative damage and stress in aging , 2004, Mechanisms of Ageing and Development.

[22]  J. Gambini,et al.  Mitochondrial oxidant generation is involved in determining why females live longer than males. , 2007, Frontiers in bioscience : a journal and virtual library.

[23]  M. Reed,et al.  The effects of aging on tumor growth and angiogenesis are tumor‐cell dependent , 2007, International journal of cancer.

[24]  J. Boeke,et al.  The biochemistry of sirtuins. , 2006, Annual review of biochemistry.

[25]  A. Barqawi,et al.  Testosterone replacement therapy and the risk of prostate cancer. Is there a link? , 2006, International Journal of Impotence Research.

[26]  T. Ratliff.  TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[27]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[28]  A. Ullrich,et al.  Oxidative and Osmotic Stress Signaling in Tumor Cells Is Mediated by ADAM Proteases and Heparin-Binding Epidermal Growth Factor , 2004, Molecular and Cellular Biology.

[29]  J. Mellon,et al.  Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). , 2003, International journal of oncology.

[30]  W. Zhong,et al.  Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness. , 2007, Free radical biology & medicine.

[31]  I. Fabregat,et al.  The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. , 2009, Biochimica et biophysica acta.

[32]  M. Lucia,et al.  Potential pathologic markers for prostate chemoprevention studies. , 2004, The Urologic clinics of North America.

[33]  Aubrey D N J de Grey,et al.  Protagonistic pleiotropy: Why cancer may be the only pathogenic effect of accumulating nuclear mutations and epimutations in aging. , 2007, Mechanisms of ageing and development.

[34]  E. Bruckheimer,et al.  bcl‐2 antagonizes the combined apoptotic effect of transforming growth factor‐β and dihydrotestosterone in prostate cancer cells , 2002, The Prostate.

[35]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[36]  J. L. MnSOD.  Manganese Superoxide Dismutase ( MnSOD ) , 2001 .

[37]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[38]  M. Bosland.  The role of steroid hormones in prostate carcinogenesis. , 2000, Journal of the National Cancer Institute. Monographs.

[39]  C. Autexier,et al.  Telomerase, Senescence and Ageing , 2007 .

[40]  T. Brown,et al.  Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the brown Norway rat prostate. , 2001, Endocrinology.

[41]  J. Raynaud.  Prostate cancer risk in testosterone-treated men , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[42]  M. Day,et al.  The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis , 2008, Oncogene.

[43]  L. Brass,et al.  Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. , 2004, Molecular cancer research : MCR.

[44]  P. Nelson,et al.  Association of Megalin Genetic Polymorphisms with Prostate Cancer Risk and Prognosis , 2008, Clinical Cancer Research.

[45]  Geert J. P. L. Kops,et al.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress , 2002, Nature.

[46]  Ricky A. Sharma,et al.  Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. , 2005, European journal of cancer.

[47]  Wen-Sheng Wu.  The signaling mechanism of ROS in tumor progression , 2007, Cancer and Metastasis Reviews.

[48]  D. Moscatelli,et al.  TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts , 2005, The Journal of cell biology.

[49]  M. Kawada,et al.  Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. , 2006, Cancer research.

[50]  N. Sharpless,et al.  INK4a/ARF: a multifunctional tumor suppressor locus. , 2005, Mutation research.

[51]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[52]  J. Fitzpatrick,et al.  WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER? , 2007, BJU international.

[53]  V. Anisimov.  Effect of host age on tumor growth rate in rodents. , 2006, Frontiers in bioscience : a journal and virtual library.

[54]  B. Wilson,et al.  Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. , 2007, Neoplasia.

[55]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[56]  F. Muller,et al.  Trends in oxidative aging theories. , 2007, Free radical biology & medicine.

[57]  B. Bao,et al.  Protective role of 1α, 25‐dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells , 2008, International journal of cancer.

[58]  M. López-Lázaro,et al.  Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. , 2007, Cancer letters.

[59]  G. Jenster,et al.  Evolution of the androgen receptor pathway during progression of prostate cancer. , 2006, Cancer research.

[60]  R. Cutler,et al.  Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Y. Okada,et al.  ADAMs in cancer cell proliferation and progression , 2007, Cancer science.

[62]  K. Korach,et al.  The role of estrogens and estrogen receptors in normal prostate growth and disease , 2008, Steroids.

[63]  A. D. Grey.  The reductive hotspot hypothesis of mammalian aging , 2002 .

[64]  Ruma Banerjee,et al.  Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. , 2007, Antioxidants & redox signaling.

[65]  D. Bostwick,et al.  Human prostate cancer risk factors , 2004, Cancer.

[66]  H. Poel.  Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. , 2005 .

[67]  G. Wilding,et al.  JunD mediates androgen‐induced oxidative stress in androgen dependent LNCaP human prostate cancer cells , 2008, The Prostate.

[68]  J. Han,et al.  A modular network model of aging , 2007, Molecular systems biology.

[69]  E. Ravussin,et al.  Energy metabolism and oxidative stress , 2006, Endocrine.

[70]  G. Schwartz.  Vitamin D and intervention trials in prostate cancer: from theory to therapy. , 2009, Annals of epidemiology.

[71]  F. Marshall,et al.  Increased Nox1 and hydrogen peroxide in prostate cancer , 2005, The Prostate.

[72]  M. Blasco,et al.  Cancer and ageing: convergent and divergent mechanisms , 2007, Nature Reviews Molecular Cell Biology.

[73]  W. Isaacs,et al.  Prostate carcinogenesis and inflammation: emerging insights. , 2005, Carcinogenesis.

[74]  J. Witte,et al.  COX-2 genetic variation, NSAIDs, and advanced prostate cancer risk. , 2006 .

[75]  H. Remmen,et al.  Oxidative damage to mitochondria and aging , 2001, Experimental Gerontology.

[76]  P. Nelson,et al.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. , 2008, Cancer research.

[77]  C. Hoppel,et al.  Oxidative phosphorylation and aging , 2006, Ageing Research Reviews.

[78]  Shuk-Mei Ho,et al.  Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. , 2007, The American journal of pathology.

[79]  D. Bostwick,et al.  Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer , 2000, Cancer.

[80]  J. Feng,et al.  Nutraceutical interventions may delay aging and the age-related diseases , 2000, Experimental Gerontology.

[81]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[82]  G. Bartsch,et al.  Expression and function of androgen receptor coactivators in prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[83]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[84]  W. Sellers,et al.  PTEN Nuclear Localization Is Regulated by Oxidative Stress and Mediates p53-Dependent Tumor Suppression , 2008, Molecular and Cellular Biology.

[85]  M. Bauer,et al.  Is the Val16Ala manganese superoxide dismutase polymorphism associated with the aging process? , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[86]  R. Meacham,et al.  Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. , 2008, Cancer research.

[87]  M. Blasco.  The epigenetic regulation of mammalian telomeres , 2007, Nature Reviews Genetics.

[88]  J. Issa,et al.  Age-Related DNA Methylation Changes in Normal Human Prostate Tissues , 2007, Clinical Cancer Research.

[89]  M. Emond,et al.  Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.

[90]  M R Cullen,et al.  Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.

[91]  I. Thompson,et al.  SELECT: the selenium and vitamin E cancer prevention trial. , 2003, Urologic oncology.

[92]  G. Wilding,et al.  Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. , 1997, Journal of the National Cancer Institute.

[93]  H. G. van der Poel.  Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. , 2005, European urology.

[94]  S. Batra,et al.  Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. , 2003, International journal of oncology.

[95]  N. Polissar,et al.  Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[96]  M. Cronauer,et al.  Transforming growth factor-beta in benign and malignant prostate. , 1999, The Prostate.

[97]  S. Pääbo,et al.  Gene expression becomes heterogeneous with age , 2006, Current Biology.

[98]  N. Polissar,et al.  Age-related radical-induced DNA damage is linked to prostate cancer. , 2001, Cancer research.

[99]  D. Spitz,et al.  Redox signaling in cancer biology. , 2006, Antioxidants & redox signaling.

[100]  T. Nagy,et al.  Erratum: SIRT1 is significantly elevated in mouse and human prostate cancer (Cancer Research (2007) 67, (6612-6618)) , 2007 .

[101]  M. Gleave,et al.  Protection of androgen‐dependent human prostate cancer cells from oxidative stress‐induced DNA damage by overexpression of clusterin and its modulation by androgen , 2004, The Prostate.

[102]  A. Levine,et al.  The tumor suppressor p53: Cancer and aging , 2008, Cell cycle.

[103]  H. Klocker,et al.  Identification of genes involved in estrogenic action in the human prostate using microarray analysis. , 2004, Genomics.

[104]  N. Reyes,et al.  Aging‐associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis , 2005, The Prostate.

[105]  A. Kristal,et al.  Polymorphisms in Oxidative Stress–Related Genes Are Not Associated with Prostate Cancer Risk in Heavy Smokers , 2007, Cancer Epidemiology Biomarkers & Prevention.

[106]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[107]  M. Cronauer,et al.  Transforming growth factor‐β in benign and malignant prostate , 1999 .

[108]  T. Kensler,et al.  Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element , 2005 .

[109]  P. Tuohimaa,et al.  25‐Hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  S. North,et al.  Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. , 2005, Cancer letters.

[111]  P. Chumakov,et al.  The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.

[112]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[113]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[114]  Masayuki Yamamoto,et al.  Carcinogenesis and transcriptional regulation through Maf recognition elements , 2007, Cancer science.

[115]  W. Dröge,et al.  Oxidative stress and aberrant signaling in aging and cognitive decline , 2007, Aging cell.

[116]  J. Droz,et al.  Insulin-Like Growth Factor (IGF) family and prostate cancer. , 2006, Critical reviews in oncology/hematology.

[117]  A. D. de Grey.  The reductive hotspot hypothesis of mammalian aging: membrane metabolism magnifies mutant mitochondrial mischief. , 2002, European journal of biochemistry.

[118]  A. Roessner,et al.  The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. , 2005, International journal of oncology.

[119]  M. Gleave,et al.  Differential regulation of IGFBP‐3 by the androgen receptor in the lineage‐related androgen‐dependent LNCaP and androgen‐independent C4‐2 prostate cancer models , 2006, The Prostate.

[120]  J. Witte,et al.  COX2 genetic variation, NSAIDs, and advanced prostate cancer risk , 2007, British Journal of Cancer.

[121]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[122]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[123]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[124]  H. Huber,et al.  TGF-β dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cells , 2007, Comparative Hepatology.

[125]  P. Pelicci,et al.  Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? , 2007, Nature Reviews Molecular Cell Biology.

[126]  G. Bartsch,et al.  Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth , 2002, Molecular and Cellular Endocrinology.